Literature DB >> 21294990

Antidepressant use in the absence of common mental disorders in the general population.

Jina Pagura1, Laurence Y Katz, Ramin Mojtabai, Benjamin G Druss, Brian Cox, Jitender Sareen.   

Abstract

OBJECTIVE: To examine the prevalence of antidepressant use in the absence of lifetime mental disorders and to examine sociodemographic correlates, indicators of need (hospitalization, suicidal behavior, perceived need, subthreshold disorders, disability, traumatic events), and antidepressant characteristics of such use.
METHOD: Data came from the Collaborative Psychiatric Epidemiologic Surveys (N = 20,013), a nationally representative cross-sectional sample of community-dwelling adults in the United States. Sociodemographic correlates and indicators of need were examined as predictors of past-year use of antidepressants in the absence of a lifetime DSM-IV diagnosis as assessed by the World Mental Health Composite Diagnostic Interview. The surveys were conducted between 2001 and 2003.
RESULTS: Among individuals who took an antidepressant in the past year (n = 1,441), 396 (26.3%) did not meet criteria for any lifetime diagnosis assessed. Respondents taking antidepressants in the absence of a lifetime diagnosis tended to be older, white, and female. All indicators of need except past-year suicidal behavior were significant predictors (adjusted odds ratios ranging from 2.12 to 14.22, P < .001), with 89% of individuals taking antidepressants in the absence of a lifetime diagnosis endorsing at least 1 indicator of need. Individuals taking antidepressants in the absence of a DSM-IV disorder were more likely to have been prescribed these medications by family physicians or other doctors compared to psychiatrists.
CONCLUSIONS: These results suggest that antidepressant use among individuals without psychiatric diagnoses is common in the United States and is typically motivated by other indicators of need. These findings have important implications for the delivery of medical and psychiatric care and psychiatric nosology. © Copyright 2011 Physicians Postgraduate Press, Inc.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21294990     DOI: 10.4088/JCP.09m05776blu

Source DB:  PubMed          Journal:  J Clin Psychiatry        ISSN: 0160-6689            Impact factor:   4.384


  17 in total

1.  National Trends in Antidepressant, Benzodiazepine, and Other Sedative-Hypnotic Treatment of Older Adults in Psychiatric and Primary Care.

Authors:  Donovan T Maust; Frederic C Blow; Ilse R Wiechers; Helen C Kales; Steven C Marcus
Journal:  J Clin Psychiatry       Date:  2017-04       Impact factor: 4.384

2.  Explaining the variation between practices in the duration of new antidepressant treatment: a database cohort study in primary care.

Authors:  Christopher Burton; Isobel Cameron; Niall Anderson
Journal:  Br J Gen Pract       Date:  2015-02       Impact factor: 5.386

3.  Antidepressant use and lifetime history of mental disorders in a community sample: results from the Baltimore Epidemiologic Catchment Area Study.

Authors:  Yoichiro Takayanagi; Adam P Spira; O Joseph Bienvenu; Rebecca S Hock; Michelle C Carras; William W Eaton; Ramin Mojtabai
Journal:  J Clin Psychiatry       Date:  2015-01       Impact factor: 4.384

4.  National prevalence of receipt of antidepressant prescriptions by persons without a psychiatric diagnosis.

Authors:  Gregory E Simon; Christine Stewart; Arne Beck; Brian K Ahmedani; Karen J Coleman; Robin R Whitebird; Frances Lynch; Ashli A Owen-Smith; Beth E Waitzfelder; Stephen B Soumerai; Enid M Hunkeler
Journal:  Psychiatr Serv       Date:  2014-07       Impact factor: 3.084

5.  Trends in the dispensation of antidepressant drugs over the past decade (2000-2010) in Andalusia, Spain.

Authors:  M C González-López; C M Rodríguez-López; T Parrón-Carreño; J D Luna; E Del Pozo
Journal:  Soc Psychiatry Psychiatr Epidemiol       Date:  2014-12-20       Impact factor: 4.328

6.  Escitalopram reduces attentional performance in anxious older adults with high-expression genetic variants at serotonin 2A and 1B receptors.

Authors:  Eric J Lenze; David Dixon; Petra Nowotny; Francis E Lotrich; Peter M Doré; Bruce G Pollock; Anthony L Hinrichs; Meryl A Butters
Journal:  Int J Neuropsychopharmacol       Date:  2012-04-17       Impact factor: 5.176

7.  Suicide mortality in relation to dietary intake of n-3 and n-6 polyunsaturated fatty acids and fish: equivocal findings from 3 large US cohort studies.

Authors:  Alexander C Tsai; Michel Lucas; Olivia I Okereke; Eilis J O'Reilly; Fariba Mirzaei; Ichiro Kawachi; Alberto Ascherio; Walter C Willett
Journal:  Am J Epidemiol       Date:  2014-05-08       Impact factor: 4.897

Review 8.  Depression, antidepressants, and bone health in older adults: a systematic review.

Authors:  Marie Anne Gebara; Marcie L O Shea; Kim L Lipsey; Steven L Teitelbaum; Roberto Civitelli; Daniel J Müller; Charles F Reynolds; Benoit H Mulsant; Eric J Lenze
Journal:  J Am Geriatr Soc       Date:  2014-07-15       Impact factor: 5.562

9.  Initiation of new psychotropic prescriptions without a psychiatric diagnosis among US adults: Rates, correlates, and national trends from 2006 to 2015.

Authors:  Taeho Greg Rhee; Robert A Rosenheck
Journal:  Health Serv Res       Date:  2018-10-17       Impact factor: 3.402

10.  Antidepressants are not overprescribed for mild depression.

Authors:  Gregory E Simon; Rebecca C Rossom; Arne Beck; Beth E Waitzfelder; Karen J Coleman; Christine Stewart; Belinda Operskalski; Robert B Penfold; Susan M Shortreed
Journal:  J Clin Psychiatry       Date:  2015-12       Impact factor: 4.384

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.